Studies on the potency of various antitussive agents

Area of Science:

• Pharmacology
• Neuroscience
• Respiratory Medicine

Background:

• Cough suppression is a critical therapeutic goal.
• Understanding the central mechanisms of cough and the efficacy of antitussive agents is essential for developing effective treatments.
• The cough center is localized in the brainstem, with a specific reactive region identified.

Purpose of the Study:

• To evaluate and compare the antitussive potency of several agents, including dextromethorphan, codeine, clonazepam, and diazepam.
• To determine the minimal effective doses for centrally induced cough suppression in feline models.
• To investigate the relationship between antitussive and muscle relaxant activities of benzodiazepines.

Main Methods:

• Electrical stimulation of the lower brainstem in anesthetized and unanesthetized feline preparations to induce cough responses.
• Recording of cough sounds using a microphone.
• Intravenous administration of graded doses of antitussive agents to determine minimal effective doses (MEDs).

Main Results:

• The minimal effective doses (mg/kg) for dextromethorphan, RO 21-4790-001, codeine, clonazepam, diazepam, and caramiphen were 0.57, 2.55, 1.71, 0.048, 0.28, and 3.18, respectively.
• Clonazepam exhibited the highest antitussive potency, with an MED approximately 1/35 that of codeine.
• Antitussive potency of benzodiazepines did not correlate with muscle relaxant activity; clonazepam was six times more potent than diazepam as an antitussive despite similar muscle relaxant effects.

Conclusions:

• Clonazepam is a highly potent antitussive agent.
• The findings suggest a high specificity of clonazepam for cough suppression.
• Benzodiazepines may possess distinct mechanisms for antitussive and muscle relaxant effects.